Elubrixin

DB12135InvestigationalSmall molecule

Elubrixin has been used in trials studying the treatment of Cystic Fibrosis, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease (COPD).

Chemical structure of Elubrixin
Mechanism
Curator reviewed
Formula / weight
C17H17Cl2FN4O4S · 463.31 g/mol (avg)
Code names
SB-656933 · SB-656933-AAF

Resolves to

Compound
UNIIMW2AIJ8USPCAS688763-64-6ChEMBLCHEMBL2178579PubChem10479502
Structure
InChIKeyYQYFEGTYCUQBEI-UHFFFAOYSA-NSMILESOC1=C(C(Cl)=CC=C1NC(=O)NC1=C(Cl)C(F)=CC=C1)S(=O)(=O)N1CCNCC1
Targets
P25025CXCR2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Elubrixin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In